News

rfxcel, a global leader in digital supply chain traceability solutions,  announced that it had entered into an acquisition agreement with Italy’s Antares Vision Group, a leading global provider of intelligent track and trace, inspection, and smart data management solutions...

Russia has granted approval to its third Covid-19 vaccine for domestic use, with large-scale clinical trials yet to begin. Produced by the Chumakov Centre, CoviVac is a whole-virion vaccine, which derives from inactivated coronavirus, Reuters reported. The vaccine shot, transported...

Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced the complete enrollment of PREVENT-19, its pivotal Phase 3 study in the United States and Mexico to evaluate the efficacy, safety and immunogenicity of the company’s...

Sanofi has entered into an agreement with Janssen Pharmaceutical NV and Janssen Pharmaceuticals, Inc., two of the Janssen Pharmaceutical Companies of Johnson & Johnson, under which Sanofi will support manufacturing of Janssen´s COVID-19 vaccine in order to address the...

Eisai Co., Ltd. has received the 18th Corporate Philanthropy Award (FY 2020) of the Japan Philanthropic Association. The presentation ceremony was held on last Friday, February 19, 2021 at the GakushiKaikan (Chiyoda-ku, Tokyo). The Corporate Philanthropy Award was founded in...

Gan & Lee Pharmaceuticals Co Ltd, a global biopharmaceutical company, has announced a Collaborating association with the International Diabetes Federation (IDF) that seeks to support its global effort to promote diabetes care and prevention worldwide. This collaboration will enable...

Eli Lilly and Company and Rigel Pharmaceuticals, Inc. announced a global exclusive license agreement and strategic collaboration to co-develop and commercialize Rigel's R552, a receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitor, for all indications including autoimmune and inflammatory diseases. Pursuant...